Intraperitoneal Oxaliplatin in Combo w IV mFOLFIRI for Peritoneal Carcinomatosis From Colorectal & Appendiceal Cancer

NCT04158349 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped PI Decision

Conditions

Colorectal Cancer
Appendiceal Cancer
Peritoneal Carcinoma

Interventions

DRUG: Oxaliplatin
DRUG: mFOLFIRI

Sponsor

University of Utah